Is Ozempic still covered by TRICARE for diabetes

Yes. TRICARE still covers Ozempic, Mounjaro, Trulicity, and Victoza for all patients to treat diabetes when medically necessary [1]. The August 31, 2025 change applies to weight loss drug coverage, not medically necessary diabetes treatment with these named drugs. Your refill still follows the plan and pharmacy rules that apply to your TRICARE status.

Does TRICARE For Life cover Ozempic for weight loss

TRICARE For Life beneficiaries lost weight loss drug coverage on August 31, 2025, and approved prior authorizations for weight loss drugs are no longer valid [1][2]. That change does not erase TRICARE coverage for Ozempic, Mounjaro, Trulicity, or Victoza when they are used to treat diabetes and medically necessary [1]. The diagnosis and claim lane matter.

Can Ozempic and Wegovy be used together under the TRICARE weight loss form

No. The TRICARE weight management form says the requested drug cannot be combined with another GLP-1 medication such as Ozempic, Trulicity, or Mounjaro. The weight loss form does not approve uses outside the FDA label, including diabetes [4]. Diabetes treatment and weight loss treatment must be handled through the applicable coverage path.

Which TRICARE plans kept weight loss drug coverage

TRICARE Prime and TRICARE Select, including Prime Remote, Young Adult, Reserve Select, and Retired Reserve variants, keep weight loss medication coverage in certain circumstances [2]. The medication must be prescribed by a network or TRICARE-authorized provider, be medically necessary, and have a maintained prior authorization [1][3]. The final call sits with the plan.

What should I check before my Ozempic refill this week

Check that the prescription is being processed for diabetes treatment, then confirm your TRICARE status and the pharmacy handling the refill. If the pharmacy says prior authorization is missing, ask whether the issue is the diabetes claim or a weight loss request. Do not use the TRICARE weight management form to request diabetes coverage, because that form does not approve uses outside the FDA label, including diabetes [4].

TRICARE and Ozempic, diabetes coverage vs weight loss rules

If your TRICARE prescription is Ozempic for medically necessary diabetes treatment, the August 31, 2025 weight loss change does not remove that coverage. TRICARE still covers Ozempic, Mounjaro, Trulicity, and Victoza for all patients to treat diabetes when medically necessary [1]. The change affects weight loss drug coverage. TRICARE For Life and direct-care-only beneficiaries, plus NATO or Partnership for Peace members, lost weight loss drug coverage and their approved prior authorizations are no longer valid, while TRICARE Prime and TRICARE Select, plus the premium-based plans listed by TRICARE, keep coverage behind prior authorization [1][2].

Is my Ozempic refill affected by the August 31, 2025 change?

The clean answer is to identify the use on the prescription. Ozempic remains in the diabetes lane. TRICARE still covers Ozempic, Mounjaro, Trulicity, and Victoza for all patients to treat diabetes when medically necessary [1]. That rule is separate from the weight loss medication policy.

The August 31, 2025 change is about weight loss drugs. TRICARE For Life and direct-care-only beneficiaries, along with NATO or Partnership for Peace members, lost weight loss drug coverage and their approved prior authorizations are no longer valid, while TRICARE Prime and TRICARE Select, plus the premium-based plans listed by TRICARE, keep coverage behind prior authorization [1][2].

That means a retiree on TFL checking an Ozempic refill should not treat the TFL status alone as an answer. The purpose of the prescription matters. A diabetes refill follows the diabetes coverage rule. A request for weight loss treatment follows the weight loss rule, where plan status controls whether coverage remains available.

If a pharmacy rejection appears, ask what claim lane produced it. The issue could be the diagnosis attached to the prescription, a missing authorization, the pharmacy network, or a plan rule. The official TRICARE Weight Loss Products page has the benefit source, and the final call sits with TRICARE and the pharmacy contractor.

What is the difference between Ozempic and the weight loss drug list?

TRICARE names Ozempic, Mounjaro, Trulicity, and Victoza as covered for all patients when used to treat diabetes and medically necessary [1]. The weight loss list is different. It includes Wegovy, Zepbound, Contrave, Qsymia, and phentermine [3].

Do not collapse those lists into a general GLP-1 rule. A medication name does not tell you which coverage pathway is being used. Ozempic is named in the diabetes coverage rule. Wegovy and Zepbound are handled through the weight management prior authorization process. The claim needs to match the covered use and the plan rules.

The TRICARE weight management form covers semaglutide injection, Wegovy, and tirzepatide injection, Zepbound, for its adult pathway at age 18 and older [4]. It requires a BMI of 30 or higher, or a BMI of 27 or higher with at least one listed weight-related comorbidity, including diabetes, impaired glucose tolerance, dyslipidemia, hypertension, and sleep apnea [4]. It also asks for behavioral modification and dietary restriction for at least 6 months that failed to reach the desired weight loss [4].

That form does not turn an Ozempic request into a weight loss request. It also does not approve uses outside the FDA label, including diabetes [4]. If your prescription is for diabetes, the weight management form is not the document that decides that diabetes claim.

For the separate Wegovy rules, see TRICARE Wegovy coverage. For the date and plan split, see the August 2025 TRICARE weight loss change.

Who lost weight loss coverage, and who kept it?

As of August 31, 2025, TRICARE For Life and direct-care-only beneficiaries, along with NATO or Partnership for Peace members, lost weight loss drug coverage and their approved prior authorizations are no longer valid [1][2]. Weight loss drug prescriptions cannot be filled at military pharmacies, and an excluded beneficiary pays 100% of the cost elsewhere even with a previously approved prior authorization [1].

TRICARE Prime and TRICARE Select enrollees keep weight loss medication coverage in certain circumstances [1][2]. The continued plans include Prime Remote, Young Adult, Reserve Select, and Retired Reserve variants, along with the Continued Health Care Benefit Program listed in the plan explanation [2]. Coverage requires a network or TRICARE-authorized provider, medical necessity, and a maintained prior authorization [1][3].

This is why the sentence TRICARE stopped covering weight loss drugs is incomplete. TRICARE For Life and direct-care-only beneficiaries, plus NATO or Partnership for Peace members, lost weight loss drug coverage and their approved prior authorizations are no longer valid, while TRICARE Prime and TRICARE Select, plus the premium-based plans listed by TRICARE, keep coverage behind prior authorization [1][2].

The split does not change the diabetes rule for Ozempic, Mounjaro, Trulicity, and Victoza. It changes the weight loss lane. Your plan status matters when you are asking for Wegovy, Zepbound, Contrave, Qsymia, or phentermine, not as a reason to erase the separate diabetes coverage rule [1][3].

Here is the distinction to screenshot:

Diabetes lane	Weight loss lane
Drugs named by TRICARE are Ozempic, Mounjaro, Trulicity, and Victoza [1]	Drugs named for weight loss are Wegovy, Zepbound, Contrave, Qsymia, and phentermine [3]
Who qualifies is all patients when treatment is for diabetes and medically necessary [1]	Coverage continues for TRICARE Prime and TRICARE Select, including listed variants and premium-based plans, in certain circumstances [1][2]
The gate is medically necessary diabetes treatment under the TRICARE coverage rule [1]	The gates are a network or TRICARE-authorized provider, medical necessity, and a maintained prior authorization [1][3]
The weight management form is not the diabetes approval path. It does not approve uses outside the FDA label, including diabetes [4]	The form asks for BMI 30 or higher, or BMI 27 or higher with a listed comorbidity, behavioral modification and dietary restriction for at least 6 months, and other criteria [4]
Ozempic is not combined with Wegovy or Zepbound through the weight loss form [4]	The requested drug cannot be combined with another GLP-1 such as Ozempic, Trulicity, or Mounjaro [4]

What does the weight loss prior authorization require?

The weight management prior authorization is a separate review. It covers Wegovy and Zepbound through the Express Scripts form, with an adult pathway at age 18 and older [4]. The form requires a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related comorbidity. Its listed comorbidities are diabetes, impaired glucose tolerance, dyslipidemia, hypertension, and sleep apnea [4].

The form also requires behavioral modification and dietary restriction for at least 6 months that failed to reach the desired weight loss, with continued engagement through the course of therapy [4]. It asks for a trial of 3 months of a generic anorexiant, such as phentermine, benzphetamine, diethylpropion, or phendimetrazine, that failed to achieve a 5% reduction in baseline weight. That trial is not required when there is a contraindication or prior adverse reaction to those drugs [4].

Initial therapy approves for 12 months, and annual renewal is required. Renewal asks for documented weight loss since starting the medication [4]. The form does not approve uses outside the FDA label, including diabetes [4].

The form also says the requested drug cannot be combined with another GLP-1 medication such as Trulicity, Ozempic, or Mounjaro [4]. So a person cannot use the weight loss form to add Wegovy or Zepbound on top of Ozempic. That is a form rule, not a statement that the diabetes coverage for Ozempic disappeared.

For a retiree checking an Ozempic refill, the practical question is not whether Ozempic belongs to a GLP-1 class. The practical question is whether the refill is being processed for medically necessary diabetes treatment under the diabetes coverage rule, or whether someone is trying to process it through the weight loss form. Those are different paths.

What if the pharmacy says my refill needs prior authorization?

Start with the exact rejection message. Prior authorization means the plan requires a request and review before the claim can be paid. The weight loss coverage rule clearly requires a maintained prior authorization for covered Prime and Select weight loss claims [1][3]. The diabetes coverage statement identifies Ozempic, Mounjaro, Trulicity, and Victoza as covered for all patients to treat diabetes when medically necessary [1].

That does not let anyone predict the result of a specific refill. The plan documents, prescription record, medical necessity review, and pharmacy contractor have the final word. If the pharmacy says prior authorization is missing, ask whether the request concerns Ozempic for diabetes or a weight loss drug request involving Wegovy or Zepbound.

Check the prescriber and pharmacy requirements too. Covered TRICARE weight loss medications must be prescribed by a TRICARE-authorized provider and filled at a network pharmacy [3]. The network provider and network pharmacy requirements in that source apply to the weight loss lane.

If you are on TFL, do not assume the August 31, 2025 change explains an Ozempic diabetes refill rejection. TFL beneficiaries lost weight loss drug coverage and their approved prior authorizations are no longer valid, while the diabetes coverage rule for Ozempic remains separately stated by TRICARE [1][2]. Ask for the denial or rejection in writing if the issue is not clear, then compare it with the official TRICARE page and the plan documents.

What to do next

Written for a retiree checking an Ozempic refill this week:

Check the prescription record and confirm whether the stated use is diabetes treatment or weight loss.
Confirm that your TRICARE status is TFL, Prime, Select, direct care only, or a listed premium-based plan before applying the weight loss rule.
Ask the pharmacy whether the rejection concerns Ozempic for diabetes or a weight loss prior authorization.
If the request is for Wegovy or Zepbound, read the Express Scripts TRICARE prior authorization request form and check its BMI, 6 months, 3 months, and other requirements [4].
Do not submit the weight management form to request diabetes coverage, because the form does not approve uses outside the FDA label, including diabetes [4].
Confirm that the prescriber and pharmacy meet the TRICARE requirements for the applicable claim lane [3].
Keep the pharmacy rejection, prescription record, prior authorization notice, and plan documents together.
Compare the result with the TRICARE coverage hub and the official TRICARE Weight Loss Products page before changing the refill request.

Sources

TRICARE, Weight Loss Products coverage page, diabetes coverage and plan exclusions, accessed 2026-08-01, https://tricare.mil/weightlossproducts
myAirForceBenefits, TRICARE coverage of weight loss medications, the August 31, 2025 plan change, accessed 2026-08-01, https://myairforcebenefits.us.af.mil/TRICARE-Coverage-of-Weight-Loss-Medications-What-To-Know
Express Scripts TRICARE pharmacy FAQ, GLP-1 and weight loss coverage, covered drugs and pharmacy requirements, accessed 2026-08-01, https://militaryrx.express-scripts.com/faq/are-glucagon-peptide-1-glp-1-and-weight-loss-medications-covered-through-tricare-pharmacy
Express Scripts, TRICARE prior authorization request form for Wegovy and Zepbound, weight management criteria and restrictions, accessed 2026-08-01, https://www.express-scripts.com/interaction/member-proxinator/1/member/v1/drugpricing/prelogin/fst/drug/forms/content?repository=EIS_P8_DC%3AesiCPS&documentId=%7BE0E89991-0000-CF1F-9F1E-DF770B00E0D2%7D